Weichang Zhou

Biography

Dr. Weichang Zhou serves as Senior Vice President, Chief Technology Officer, Executive Director of the Company. Dr. Zhou is primarily responsible for overseeing the development and manufacturing of biologics. Dr. Zhou joined our Group in December 2012 as our vice president and was appointed as our chief technology officer, senior vice president and executive Director in November 2016, April 2015 and May 2016, respectively. Dr. Zhou has worked in the following companies: From March 2008 to December 2012, he served as a senior director of Genzyme Corporation, a company primarily engaged in developing and commercializing recombinant protein and monoclonal antibody therapeutics, and was responsible for commercial cell culture process development. From October 2002 to February 2008, he served as a senior director of PDL BioPharma Inc., a biopharmaceutical company listed on NASDAQ (stock code: PDLI) and primarily engaged in developing humanized monoclonal antibody therapeutics, and was responsible for process sciences and engineering functions. Dr. Zhou obtained a bachelor’s degree in chemical engineering from Jiangxi University of Technology in the PRC in July 1982. He also obtained a Ph.D. degree in chemical engineering and biotechnology from University of Hannover in Germany in June 1989.  

Research Interest

Pharmaceutical science